A Phase I/II Study of G3139 [oblimersen] (Genasense) in Combination With RICE Chemotherapy in Relapsed B-Cell Non-Hodgkin's Lymphoma

Trial Profile

A Phase I/II Study of G3139 [oblimersen] (Genasense) in Combination With RICE Chemotherapy in Relapsed B-Cell Non-Hodgkin's Lymphoma

Completed
Phase of Trial: Phase I/II

Latest Information Update: 23 Jan 2013

At a glance

  • Drugs Oblimersen (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
  • Indications Non-Hodgkin's lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Jan 2008 Status changed from in progress to completed.
    • 27 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top